index,Regulator Name,Regulator Type,Regulator Subtype,Regulator HGNC Symbol,Regulator Database,Regulator ID,Regulator Compartment,Regulator Compartment ID,Regulated Name,Regulated Type,Regulated Subtype,Regulated HGNC Symbol,Regulated Database,Regulated ID,Regulated Compartment,Regulated Compartment ID,Sign,Connection Type,Mechanism,Site,Cell Line,Cell Type,Tissue Type,Organism,Unnamed: 0,Score,Source,Statements,Paper IDs,Evidence Score,Match Score,Kind Score,Epistemic Value,Total Score
19,akt,protein,total,akt1,uniprot,p31749,cytoplasm,go:0005737,pten,protein,,pten,uniprot,p60484,cytoplasm,go:0005737,positive,i,co-overexpression,cytoplasm,hcasmc,smooth muscle,artery,human,['519'],nan,nan,"an antibody against total akt was used as control. the potent pi3-k-inhibitor ly294002 (50 nm) was supplemented to the medium for not-transfected cells. hcasmc were transfected as follows: non transfected (nt); transfected with a plasmid coding for gfp (pcontrol); transfected with an empty plasmid without pten-cdna (pcontrol); transfected with a plasmid coding for pten (ppten); mock transfected (without plasmid, but with transfection reagent). pten- and akt co-overexpression reverses ptens pro-apoptotic effect (c). hcasmc were co-transfected with a wt form of pten and a constitutively active form of akt. an empty plasmid was used as control. following the magnetic separation of positively transfected smc, apoptosis was determined after cell growth for 24 h and expressed as mean od405 ± sd using a cell death detection elisa (#",pmc3606387,1,10,5,1,15
452,pten,protein,,pten,uniprot,p60484,,,akt,protein,,akt1,uniprot,p31749,,,negative,i,inhibit,,,,,,['690'],nan,nan,"schematic illustration of the impact of pten-δ and pten on cellular processes. pten-δ, as well as pten, inhibit akt as antagonist of the pi3k and reduce the activity of mapk jnk and p38. both signaling pathways downstream result in a decrease of migration and adhesion and trigger apoptosis",pmc6025732,1,10,5,1,15
428,pten,protein,,pten,uniprot,p60484,endoplasmic reticulum,go:0005783,akt,protein,,akt1,uniprot,p31749,endoplasmic reticulum,go:0005783,negative,i,counteracts,,,,,human,['181'],nan,nan,"we also dissected the precise contribution of pten’s lipid and protein phosphatase activities in the regulation of ca2+ signaling and apoptosis, by generating er-targeted chimeras of the pten(c124s) mutant [2], which lacks both lipid and protein phosphatase activities (er-pten(c124s)), and of the pten(g129e) mutant [4], which displays a minimal lipid phosphatase activity while retaining full protein phosphatase activity (er-pten(g129e)). using this approach, we demonstrated that the er pool of pten counteracts akt activation specifically at the er, and can thus inhibit the akt-mediated phosphorylation of ip3r3 that protects from ca2+-mediated apoptosis [43]. we concluded that the ability of er-localized pten to regulate ca2+ release from the er specifically relies on its protein phosphatase activity [15].",pmc4396696,1,10,5,1,15
510,pten,protein,,pten,uniprot,p60484,,,pik3ca,protein,,pik3ca,uniprot,p42336,,,negative,i,,,,,,,['252'],nan,nan,"next, we compared survival curves according to protein expressions (figure 2). patients with loss of pten expression showed significantly improved overall survival compared with those without pten expression loss (figure 2a, p=0.016). in contrast, pik3ca overexpression, p-akt overexpression, and negative nuclear p27 did not show significant differences in overall survival (figures 2b–d). when compared in subsets of stage i/ii and iii/iv, negative pten showed more favourable survival in advanced disease than in early disease (figures 2e and f). negative pten showed trends towards favourable survival, when compared in subsets of both pure endometrioid disease and disease other than pure endometrioid histology (figures 2g and h).",pmc3776978,1,10,5,1,15
545,pten,protein,,pten,uniprot,p60484,nucleus,go:0005634,akt,protein,,akt1,uniprot,p31749,nucleus,go:0005634,negative,i,interacts with,nucleus,,,,cells,['608'],nan,nan,"given that pten catalyzes the dephosphorylation of pi(3,4,5)p3, which is required for akt phosphorylation, it is anticipated that a role of pten would be to protect akt from de novo phosphorylation. surprisingly, pten has been shown to function as a scaffolding protein in the nuclei of the cells where it interacts with nuclear phosphorylated akt leading to its depletion from the nucleus, most likely through proteasomal degradation (173).",pmc4515857,1,10,5,1,15
560,pten,protein,,pten,uniprot,p60484,nucleus,go:0005634,er,protein,,esr1,uniprot,p03372,nucleus,go:0005634,negative,i,methylation,,,breast cancer,breast,human,['410'],nan,nan,"to determine whether pathologic features can define a subset of women who are likely to have pten alterations, we correlated the molecular events with patients variables. like an earlier study, we found that allelic loss at 10q23 region is more prevalent among patients less than 50 years of age, however, in contrast to the study, our result also underlines the implication of advanced clinical stage and er positivity in indian breast cancer patients (garcia et al., 1999). we also found a significant role of pten methylation in tumor progression. in addition, loss of pten expression has shown a strong relationship with menopausal status and tnbc even after grouping in loh positive and pten methylation subgroups. our study also found that significantly correlated quadruple group (tnbc+pten negative) is predominantly found in tumors of the large size of a postmenopausal subset.",pmc6485588,1,10,5,1,15
604,pten,protein,,pten,uniprot,p60484,plasma membrane,go:0005886,pi3k,protein,,,fplx,pi3k,,,negative,i,decrease,,u87mg,glioblastoma,,human,['858'],nan,nan,"the study of the mutational spectrum of pten in asd patients has revealed at least 25 mutations to date, of which 16 are amino-acid substitutions (table 1) (rodríguez-escudero et al., 2011; klein et al., 2013; hobert et al., 2014). more than half of these mutations have also been identified in phts patients or as somatic mutations in sporadic cancers. they are scattered along the pten phosphatase and the c2 domain, and are absent from the n-terminal and the c-terminal regions. the exact effect of asd-unique mutations on the properties of pten (i.e., residual phosphatase activity, altered membrane/protein interactions, protein stability) is still poorly characterized. a number of recent studies have suggested the possibility that asd mutations are less severe (i.e., mutant forms retain partial activity) when compared to tumor-related mutations. the mostly studied asd mutation in the context of its effect on pten activity is pten h93r. this mutation also identified in cs, appears to result in an 85% decrease in pten's pip3 phosphatase activity when measured against water-soluble pip3 in vitro. yet this mutation increased pten association with ps-rich liposomes in vitro, as well as increased membrane localization in vivo (redfern et al., 2010). notably, when compared to wild-type pten, pten h93r was unable to fully reduce pi3k-dependent akt phosphorylation in u87mg glioblastoma cells, indicating a partial loss of activity in vivo (redfern et al., 2010). also, using a heterologous yeast pi3k-activity reconstitution system, pten h93r appeared to retain residual phosphatase activity when compared to phts pten mutants (rodríguez-escudero et al., 2011). thus, it would appear that complete loss of pten phosphatase activity and/or pten stability is rather an infrequent event in asd cases (zhou and parada, 2012). however, in addition to understanding the molecular effect of these asd-unique mutations, their exact effect on the modulation of morphology and synaptic plasticity by pten awaits detailed analyses in neuronal cells.",pmc3978343,1,10,5,1,15
630,pten,protein,phosphatase,pten,uniprot,p60484,cytoplasm,go:0005737,akt,protein,kinase,akt1,uniprot,p31749,cytoplasm,go:0005737,negative,i,decrease,phosphorylation,zebrafish,embryo,whole organism,zebrafish,['58'],nan,nan,"in this study we investigated which pten phosphatase activity, lipid or protein phosphatase, is required for normal zebrafish embryonic development and angiogenesis. we tested the capacity of phosphatase activity mutants of pten to rescue the pleiotropic phenotype at 4dpf when injected as synthetic mrna at the one-cell stage. wild type pten, but none of the phosphatase mutants, was able to rescue the pleiotropic phenotype at 4dpf. in contrast to the pleiotropic phenotype at 4dpf, the hyperbranching vessel phenotype at 3dpf was rescued by both lipid phosphatase active pten constructs, pten wild type and pten y138l. further, lipid phosphatase active pten decreased activated akt (pakt) levels in pten double homozygous zebrafish embryos at 4dpf. we conclude that pten lipid phosphatase activity is required to regulate correct vessel formation and pakt levels during zebrafish embryogenesis, whereas the pten protein phosphatase activity seems dispensable for regulating angiogenensis. for correct zebrafish embryonic development, however, both lipid and protein phosphatase activities appear to be required.",pmc4743836,1,10,5,1,15
644,pten,protein,phosphatase,pten,uniprot,p60484,cytoplasm,go:0005737,pi3k,protein,kinase,pik3ca,uniprot,p42336,plasma membrane,go:0005886,negative,i,regulates,,,,,,['847'],nan,nan,"pten, a phosphoinositide 3-phosphatase that regulates pi3k (phosphoinositide 3 kinase) signaling",pmc3978343,1,10,5,1,15
372,pten,protein,,pten,uniprot,p60484,cytoplasm,go:0005737,pi3k,protein,,pik3cg,uniprot,p48736,cytoplasm,go:0005737,negative,i,induction,,,melanoma,,human,['545'],nan,nan,"loss of pten plays an important role in the development of 30–60% of melanomas, however, the mechanisms by which loss of this gene leads to tumor formation remain uncertain. recent evidence has shown that decreased pten transcript levels were associated with pten promoter methylation in melanoma (34, 50). wang et al. showed that more than 50% of the melanomas from patients with xeroderma pigmentosum display pten mutations, typically related to ultraviolet radiation exposure, highlighting the link between dna-damage and pten mutations in this disease (51). dankort et al. have demonstrated the ability of pten silencing to cooperate with brafv600e mutations in the genesis of metastatic melanoma (52). several research groups have recently demonstrated that mek blockade may induce compensatory signaling through pi3k pathway in melanoma, inducing its own resistance factors and explaining the highly variable clinical responses to mek inhibition in different cellular contexts (106, 131, 176–178). without a doubt, pten status is critical in determining the functional outcome of pharmacologic mek inhibition in melanoma and in cellular contexts in which pten is genetically unaltered, mek blockade induces a cross-talk mechanism that leads to pten protein induction, playing an important, albeit not exclusive, role in the anti-tumor and anti-angiogenic activities of mek inhibitors (106). consistently, pten loss impairs the anti-tumor activity of mek inhibitors in preclinical models (106, 179, 180) and correlates with decreased efficacy of braf-targeted treatments in metastatic melanoma patients (53).",pmc4329810,1,10,5,1,15
371,pten,protein,,pten,uniprot,p60484,cytoplasm,go:0005737,pi3k,protein,,pik3ca,uniprot,p42336,plasma membrane,go:0005886,negative,i,regulation,,,,,,['531'],nan,nan,selected cell functions controlled by specific pten activities/domains and their dependency on regulation of the pi3k pathway.,pmc4329810,1,10,5,1,15
361,pten,protein,,pten,uniprot,p60484,cytoplasm,go:0005737,mtorc2,proteincomplex,,,,,cytoplasm,go:0005737,negative,i,phosphorylation,thr1135,,,,human,['205'],nan,nan,"mutation of pten is associated with high-grade gbm formation. mtorc2 is emerging as a potential drug target in pten-mutated cancers. the detailed mechanism of molecular regulation and cross-talk between pten and mtorc2 is still not clearly known. accordingly, we investigated the role of pten in mtorc2 regulation and signaling in gbm. the major achievement of this study is providing evidence that ptenmu cells exhibit enhanced mtorc2 formation and signaling because of the decreased inhibitory phosphorylation of rictor (thr1135). this is the first evidence suggesting thr1135 phosphorylation of rictor is controlled by pten, and demonstrates pten as the master regulatory molecule in mtorc2 formation. in addition, we have established mahanine, carbazole alkaloid from an edible plant, as a potential mtorc1/2 inhibitor that showed cytotoxicity both in ptenmu/ptenwt cells.",pmc4945751,1,10,5,1,15
674,pten,protein,tumor suppressor,pten,uniprot,p60484,cytoplasm,go:0005737,pi3k,protein,kinase,pik3ca,uniprot,p42336,plasma membrane,go:0005886,negative,i,dephosphorylation,lipid,,prostate,,human,['3'],nan,nan,"pten is a tumor suppressor protein widely recognized as a negative regulator of the pi3k/akt signaling pathway (reviewed in ref. 17). pten function is frequently lost in prostate cancer and a recent study demonstrated aberrations in the pten gene in 41% of 150 individuals with metastatic, castration-resistant prostate cancer in a large multiinstitutional sequencing study18. although pten acts as a lipid phosphatase that dephosphorylates phosphatidylinositol (3,4,5)-trisphosphate (pip3) to phosphatidylinositol (4,5)-bisphosphate (pip2)19, 20, it was initially identified as a protein phosphatase that is able to target serine, threonine, and tyrosine residues21, 22. more recently, additional phosphatase and pi3k/akt-independent functions have also been identified for pten23.",pmc5688148,1,10,5,1,15
685,pten,protein,tumor suppressor,pten,uniprot,p60484,,,pi3k,protein,,,,,,,negative,i,mrna regulation,3′utr,,,,,['417'],nan,nan,"pten is an important tumor suppressor, and loss of pten function has been implicated in a wide variety of tumor types11. the pten-pi3k-akt-mtor pathway plays an essential role in the regulation of glucose metabolism, owing to its position downstream of the insulin receptor (insr) and irs adaptor molecules. increasing evidence supports the hypothesis that mrnas can serve as regulatory rnas. pten mrna functions in the regulation of gene expression by competing with common micrornas12. pten expression can be post-transcriptionally modulated by a pten pseudogene, whose transcripts exert regulatory control of their ancestral cancer gene's expression levels by competing with micrornas that target sequences common to the mrna and the pseudo-mrna13,14. however, whether the pten mrna 3′utr contains hairpin structure and functions in regulation are not well documented.",pmc4933753,1,10,5,1,15
252,pten,protein,lipid phosphatase,pten,uniprot,p60484,extracellular space,go:0005615,akt,protein,,akt1,uniprot,p31749,cytoplasm,go:0005737,negative,i,reduce akt phosphorylation,,,,,human,['170'],nan,nan,"recently two different groups have reported that pten is also secreted/exported outside the cell. putz et al. [16] demonstrated that pten is exported in exosomes under the control of nedd4 family-interacting protein 1 (ndfip1), an adaptor protein for the nedd4 ubiquitin ligase; extracellular pten is then internalized by recipient cells and is able to reduce akt phosphorylation and cell proliferation. hopkins et al. [17] identified a previously uncharacterized form of pten containing an additional 173 amino acids at the n-terminal of the 403-amino acid-long wt pten protein (named pten-long), which resulted from an alternate translation initiation site. this longer form of pten is a membrane-permeable lipid phosphatase that is secreted from cells, and is capable of entering other cells where it antagonizes the pi3k signaling pathway.",pmc4396696,1,10,5,1,15
247,pten,protein,lipid phosphatase,pten,uniprot,p60484,cell membrane,go:0005886,pi3k,protein,,pik3r1,uniprot,p27986,plasma membrane,go:0005886,negative,i,dephosphorylates,ptdinsp3,,embryo,caudal,chick,['645'],nan,nan,"pten belongs to a superfamily of protein tyrosine phosphatase that simultaneously possess robust phosphatase activity against lipids and proteins (leslie et al., 2009). presently, we have investigated the role of pten and cell migration in the context of protein phosphatase activity. raftopoulou et al. reported that cell migration was inhibited following microinjection of the c2 domain of pten into glioblastoma cells (raftopoulou et al., 2004). we have also reported similar phenotype by demonstrating that the protein phosphatase of pten modulated in the emt process of chick anterior primitive streak during gastrulation (leslie et al., 2007). however, in our scenario, we discovered that the principal function of pten lipid phosphatase was to regulate cell migration in the caudal embryo. we have shown that pi3k-akt signaling was very active during chick gastrulation and that silencing pten expression in turn reduces akt expression. this implies that pten dephosphorylates ptdinsp3 through its lipid phosphatase. furthermore, when pi3k signaling was inhibited with ly294002 inhibitor, it resulted in the primary vascular plexus being formed as an aggregated mass of blood islands in the yolk-sac. these findings strongly suggest that pten exerted its effect on vasculogenesis primarily through pten lipid phosphatase activity.",pmc3683161,1,10,5,1,15
244,pten,protein,gene,pten,,,nucleus,go:0005634,akt,protein,,,,,cytoplasm,go:0005737,negative,i,inhibition,,,,,human,['550'],nan,nan,"although mutations of the pten gene appear to be generally rare in hematological tumors (59), its functional inactivation is frequently observed in several hematopoietic neoplasms (60–62, 186). experiments conducted in mice with inducible pten deletions have demonstrated that loss of pten drives proliferation of leukemia-initiating cells and promotes leukemogenesis. pi3k pathway blockade prevents leukemogenesis and restores the normal self-renewing capacity of hematopoietic stem cells (63, 64). cheong et al. have shown that reduction of pten phosphorylation, associated with its inactivity, is observed in approximately 75% of acute myeloid leukemia (aml) patients (65). another study has shown that aberrant pten transcripts are present in 24% of aml patients, 80% of cell lines, and 13% of normal controls analyzed (66). in chronic myeloid leukemia (cml), the bcr–abl fusion protein mediates the exclusion of pten from the nucleus. such effect is reversed upon inactivation of bcr–abl by imatinib treatment, which restores pten physiological localization localization (67). recently, it has been shown that pten loss accelerates t-cell acute lymphoblastic leukemia (t-all) onset, producing multiclonal tumors (68, 69). notch1 receptor may inhibit pten expression through the hes-1 transcription factor and this may in turn lead to akt activation and resistance to glucocorticoids (70). indeed, t-all with pten loss are resistant to notch1 inhibitors while they are sensitive to akt inhibitors (68).",pmc4329810,1,10,5,1,15
241,pten,protein,dual-specificity lipid- and protein phosphatase,pten,,,,,pi3k,protein,,,,,,,negative,i,inhibiting,,,vsmc,neointimal,mouse,['503'],nan,nan,"the phosphatase and tensin homology deleted on chromosome 10 (pten), has been identified as a prominent tumor suppressor protein and important regulator of cell growth and apoptosis. pten acts as a dual-specificity lipid- and protein phosphatase and hydrolyzes the 3-phosphoinositide lipid products of pi3k thereby inhibiting the activation of a number of effector molecules downstream of pi3k [3], [4]. in a recent report, pdgf-induced proliferation and migration of vsmc as well as neointimal hyperplasia was successfully inhibited by pten-overexpression [5], [6]. deletion of pten in all mouse tissues resulted in developmental delay and lethality at e 7.5 due to unbalanced tissue growth during early embryogenesis and subsequent organ failure [7]. recently, using tamoxifen-inducible smc-specific pten knockout mice, it was documented that inactivation of pten in vivo exacerbates injury-induced neointima formation [8].",pmc3606387,1,10,5,1,15
194,pi3k,protein,,,,,,,pten,protein,,,,,,,positive,i,signaling,,,zebrafish embryo,blood vessels,zebrafish,['105'],nan,nan,"angiogenesis, the formation of new blood vessels from the existing vasculature, is a process tightly controlled by pi3k signaling and therefore a good read-out to evaluate the rescue capacity of pten mutants in pten double homozygous zebrafish embryos. in order to functionally characterize pten and pten qma in angiogenesis, we microinjected embryos from a tg(kdrl:egfp) ptena+/-ptenb-/- incross at the one-cell stage with synthetic mrna, encoding ptenb-mcherry, pten-mcherry or pten-mcherry qma. at 3dpf, we monitored the vasculature by confocal live imaging (fig 2a–2j). according to mendelian law, 25% of the offspring of a ptena+/-ptenb-/- incross was expected to be double homozygous and develop the hyperbranching phenotype (fig 2k). this percentage was reflected in the non-injected control (nic) embryos. expression of ptenb, pten or pten qma significantly decreased the percentage of embryos with the characteristic hyperbranching phenotype (fig 2d, 2f, 2h and 2k), whereas the phosphatase inactive ptenb c124s did not have this effect (fig 2j and 2k). surprisingly, we discovered a second phenotype in the ptena-/-ptenb-/- embryos and siblings expressing pten qma (fig 2g’). this phenotype consisted of the occurrence of intersegmental vessels (isv) that did not connect to the dorsal longitudinal anastomotic vessel (dlav) but instead stalled somewhere along the way. this stalled vessel phenotype might be caused by excessive activity of pten towards pip3, leading to diminished vegfr signaling. in order to test this hypothesis, we assessed the levels of phosphorylated akt, p-akt (fig 2l). our data confirmed that pten qma, as well as pten wt, reduced the elevated p-akt levels in 4dpf ptena-/-ptenb-/- embryos at least as effectively as ptenb wt. ptenb c124s lacks phosphatase activity and did not reduce p-akt levels.",pmc4854392,1,10,5,1,15
695,pten,protein,tumor suppressor gene,pten,uniprot,p60484,cytoplasm,go:0005737,akt,protein,kinase,akt1,uniprot,p31749,cytoplasm,go:0005737,negative,i,dephosphorylation,3-phosphate of the inositol ring in pip3,,,,human,['308'],nan,nan,"it has been suggested that the phosphatase and tensin homolog deleted on chromosome 10 (pten) tumor suppressor gene, one of the most commonly mutated genes in human carcinomas, plays a role in stem cell self-renewal [5]. pten can regulate side population (sp) cells which have been identified as stem-like cells [6]. in addition, pten has been found as a prognostic marker in postoperative radiotherapy for cancer of the head and neck [7]. pten functions as a phosphatase by catalyzing the dephosphorylation of the 3-phosphate of the inositol ring in phosphatidylinositol 3,4,5-trisphosphate (pip3), resulting in the biphosphate product phosphatidylinositol 4,5-bisphosphate. pip3 is critical in the activation of akt, therefore its dephosphorylation results in the inactivation of the pi3k/akt signal pathway [8]. it was reported that the pten/pi3k/akt pathway regulates stem-like cells in some primary carcinomas [9–11]. it is known that the pi3k/akt signaling pathway has been correlated with radioresistance [12–13]. however, the pi3k/akt signaling pathway has not been fully elucidated even though its activation is correlated with radioresistance. in the present study, we detected the possible molecular mechanism underlying cscs and their radioresistance in npc.",pmc5650370,1,10,5,1,15
453,pten,protein,,pten,uniprot,p60484,,,akt,protein,,akt1,uniprot,p31749,,,negative,i,,,observation group,,,,['360'],nan,nan,"protein expression levels of pten, pi3k and akt in observation group were significantly lower than those in control group (p<0.05) (fig. 2).",pmc6313102,1,10,5,1,15
699,pten,protein,tumor-suppressor,pten,uniprot,p60484,exosomes,go:1903561,pten,protein,,pten,uniprot,p60484,,,positive,i,transfer,exosomes,cancer cells,,prostate,human,['112'],nan,nan,"pten is a potent tumor-suppressor protein. aggressive and metastatic prostate cancer (pc) is associated with a reduction or loss of pten expression. pten reduction often occurs without gene mutations, and its downregulation is not fully understood. herein, we show that pten is incorporated in the cargo of exosomes derived from cancer cells. pten is not detected in exosomes derived from normal, noncancerous cells. we found that pten can be transferred to other cells through exosomes. in cells that have a reduction or complete loss of pten expression, the transferred pten is competent to confer tumor-suppression activity to acceptor cells. in pc patients, we show that pten is incorporated in the cargo of exosomes that circulate in their blood. interestingly, normal subjects have no pten expression in their blood exosomes. further, we found that the prostate-specific antigen (psa) is incorporated in pc patients’ and normal subjects’ blood exosomes. these data suggest that exosomal pten can compensate for pten loss in pten deficient cells, and may have diagnostic value for prostate cancer.",pmc3723640,1,10,3,1,13
392,pten,protein,,pten,uniprot,p60484,cytoplasm,go:0005737,pten,protein,,pten,uniprot,p60484,cytoplasm,go:0005737,positive,i,phosphorylation,,"du145, du145kd, control sirna",prostate cancer cells,,human,['121'],nan,nan,"a. du145 pc cells were transfected with the indicated sirna. the cells transfected with pten-specific sirna showed a clear knockdown of pten expression, while cells transfected with control mismatch sirna showed no decrease in pten expression. b. exosomes derived from du145, du145kd, and du145 with control sirna show the same pattern of pten expression as observed with the cell from which they originated. pten incorporated in exosomes is phosphorylated; phosphorylation protects pten from degradation, and it can be activated by dephosphorylation upon transfer to other cells. exosomes are positive for flotilin-1. c. differences in proliferation of du145, du145 with control sirna and du145kd were assessed, with significantly higher proliferation exhibited by du145kd. d. human primary cells, haec, hasmc and hpec, and their exosomes were profiled for pten expression. all three cells have pten expression, but pten is not expressed in their exosomes. the expression for both cells and their exosomes was normalized with flotilin-1. e. a scanning electron micrograph showing the shedding of exosomes from du145 cells.",pmc3723640,1,10,3,1,13
434,pten,protein,,pten,uniprot,p60484,exosomes,go:0005615,pten,protein,,pten,uniprot,p60484,other,,positive,i,transfer,exosomes,,cancer,,human,['137'],nan,nan,"different cancer cell types express pten in their exosomes, and transfer pten to other cells through exosomes. exosomes were collected from different cancer cell types, i.e. lung carcinoma (a549), breast cancer (mda-mb-231), colorectal carcinoma (hct116), and pancreas adenocarcinoma (bxpc-3). exosomes were profiled for pten expression by immunoblotting, and were positive for pten expression (a). pc-3 pten-null cells were treated with exosomes derived from hct116 cells, and acquired pten expression as shown by immunocytochemistry (b).",pmc3723640,1,10,3,1,13
391,pten,protein,,pten,uniprot,p60484,cytoplasm,go:0005737,pten,protein,,pten,uniprot,p60484,cytoplasm,go:0005737,positive,i,acquired,,pc-3 prostate cancer cells,epithelial,prostate,human,['136'],nan,nan,"pten null pc-3 prostate cancer cells acquire pten through exosomes derived from du145 cells. pc-3 cells were cultured in slide chambers and treated with du145-derived exosomes. the cells were washed three times with phosphate buffered saline (pbs), and immunocytochemistry was performed with pten primary antibodies and alexa -fluor 488 secondary antibodies. the cells were visualized using confocal microscopy (if- immunofluorescence). pc-3 cells acquired pten (green) after incubation with the exosomes.",pmc3723640,1,10,3,1,13
266,pten,protein,,,uniprot,p60484,cytoplasm,go:0005737,pten,protein,,,uniprot,p60484,cytoplasm,go:000573,positive,i,phosphorylation,,,,,,['598'],nan,nan,"interestingly, although pten phosphorylation negatively affects the phosphatase activity, it seems to increase the protein stability. more specifically, closed phosphorylated pten is less prone to ubiquitin ligases and therefore less prone to degradation in comparison to open unphosphorylated pten (122, 133).",pmc4515857,1,10,3,1,13
166,mtorc2,proteincomplex,,,uniprot,,cytoplasm,go:0005737,akt,protein,,akt1,uniprot,p31749,cytoplasm,go:0005737,positive,i,formation,,,,prostate,human,['206'],nan,nan,"mtorc2 activity is required for generation of pten deletion-induced prostate cancer.36 egfrviii-mediated activation of mtorc2 was reversed by pten activity.37 a correlation between pten and rictor was also reported in leukemogenesis.38 here we showed that ptenmu cells have higher mtorc2 formation and downstream signaling than ptenwt cells as evidenced by enhanced mtor ser2481, akt ser473 and gsk3β ser9 phosphorylations. although a correlation between pten and akt ser473 phosphorylation was reported in lung cancer and rhabdomyosarcomas, no cross-linking molecule between these phosphatase and kinase was demonstrated.39, 40 here, we showed mtorc2 is a connecting molecule between pten and akt.",pmc4945751,1,10,3,1,13
164,mtorc2,proteincomplex,,,,,,,akt,protein,,,,,,,positive,i,phosphorylation,ser473,,,,human,['189'],nan,nan,"to confirm this upstream activation of mtorc2 in ptenmu cells, we examined the phosphorylation status of a few downstream molecules. ser473 of akt is a selective substrate of mtorc2. we observed enhanced expression of phospho-akt at ser473 in ptenmu cells (figure 1d). as mtorc2 is not known to influence the thr308 of akt, we detected almost comparable levels of phosphorylation in both ptenwt/ptenmu cells (figure 1e). in addition, no significant change of akt phosphorylation at the thr450 was found. densitometric analysis of three phosphorylation sites of akt revealed that only ser473 was ~5-fold enhanced in ptenmu cells relative to ptenwt (figure 1f). this observation strongly suggested that pten mutation may have a significant role in regulating mtorc2 activity, which in turn enhanced the phosphorylation of its substrate akt at the ser473.",pmc4945751,1,10,3,1,13
422,pten,protein,,pten,uniprot,p60484,"cytoplasm, cell membrane, nucleus","go:0005737, go:0005886, go:0005634",pten,protein,,pten,uniprot,p60484,"cytoplasm, cell membrane, nucleus","go:0005737, go:0005886, go:0005634",positive,d,(de)phosphorylation,c-terminal tail,,,,,['98'],nan,nan,"during the past decade, it has become evident that controlling pten protein conformation and thereby its subcellular localization is a key regulatory mechanism to manage the variety of pten cellular functions. in its closed conformation, pten is predominantly cytoplasmic, while opening up its conformation results in re-location of pten to the cell membrane and the nucleus [8,12–15]. the conformational status of pten is predominantly regulated by post-translational modifications, especially by (de)-phosphorylation of the c-terminal tail, which alters the intramolecular interactions within pten [13,14,16,17]. pten is phosphorylated by multiple kinases, including gsk3, ck2 and atm [11,18–20]. in the context of conformational changes, especially the phosphorylation by ck2 is an important event [19]. phosphorylation on s370, s380, t382, t383 and s385 renders pten in its closed conformation, having the c-terminus folded back onto the n-terminus. upon dephosphorylation of pten at these positions, the molecule adopts the open conformation, in which newly exposed side chains and amino acid motifs relocalize pten to either the cell membrane or the nucleus, depending on the cellular context [12,15,21]. mutation of these five phosphorylation sites to alanines (s370a, s380a, t382a, t383a and s385a) mimics constitutive dephosphorylation at these sites and renders a pten mutant termed pten qma or ‘open conformation pten’ [19,22,23]. one of the motifs that is potentially exposed upon opening of the pten protein conformation is the positively charged lysine-arginine-arginine (krr) cluster within the n-terminus, which is involved in regulation of pten nuclear localization [24,25]. it has been shown that mono-ubiquitination of lysines within the n- and c- terminal tail, especially lysine 13, k13, regulates nuclear translocation of pten [26]. however, the regulation and mechanism of pten nuclear translocation as well as the identity of nuclear targets of pten remains to be determined definitively.",pmc4854392,1,10,1,1,11
162,mtorc2,complex,,,uniprot,,cytoplasm,go:0005737,akt,protein,,akt1,uniprot,p31749,cytoplasm,go:0005737,positive,d,phosphorylation,ser473,,,,,['185'],nan,nan,"mtorc1 promotes protein translation through activation of s6k1, inhibition of 4e-bp1 and enhancement of rna translation via s6 ribosomal protein.2, 14 mtorc2 can specifically phosphorylate akt at the ser473 and take part in cell proliferation, regulation and cytoskeletal reorganization.15, 16 rapamycin and its analogs (rapalogs) are used for treatment of cancers as mtorc1 inhibitors. however, inhibition of mtorc1 induces the activation of other survival pathways and thus reduces the efficacy of rapalogs.17, 18, 19 therefore, targeting mtorc2 may possibly have better therapeutic values.20 accordingly, exploration of new improved mtorc1/2 inhibitors is of great interest.",pmc4945751,1,10,1,1,11
578,pten,protein,,pten,uniprot,p60484,nucleus,go:0005634,pten,protein,,pten,uniprot,p60484,nucleus,go:0005634,positive,d,mono-ubiquitination,,,brain,,human,['365'],nan,nan,characterization of pten mutations in brain cancer reveals that pten mono-ubiquitination promotes protein stability and nuclear localization,pmc5491373,1,10,1,1,11
390,pten,protein,,pten,uniprot,p60484,cytoplasm,go:0005737,pten,protein,,pten,uniprot,p60484,cytoplasm,go:0005737,positive,d,ubiquitination,c-terminal tail,,,,human,['379'],nan,nan,"to determine whether the altered protein conformations of ptent277a and ptenl320s change the ubiquitination of pten, we co-expressed ha-ubiquitin with various gfp-pten constructs. gfp fusions were immunoprecipitated and analysed for ubiquitination by immunoblotting with anti-ha antibodies. we found that opening the protein conformation in ptena4 increased pten ubiquitination over that of ptenwt (figure 6c). as with ptena4, both ptent277a and ptenl320s showed increased ubiquitination. combinations of these mutations with a4 appear not to additionally elevate pten ubiquitination. we suggest that these elevated levels of ubiquitination likely account for protein instability in ptena4, ptent277a and ptenl320s. in contrast, by immunoblotting whole cell lysates with anti-phospho-pten antibodies, we show that t277a and l320s do not change phosphorylation at the c-terminal tail, which is necessary for interaction with the membrane-binding regulatory interface (figure 6d).",pmc5491373,1,10,1,1,11
389,pten,protein,,pten,uniprot,p60484,cytoplasm,go:0005737,pten,protein,,pten,uniprot,p60484,cytoplasm,go:0005737,positive,d,intercellular transfer,,,,,human,['123'],nan,nan,"to ensure that the increase of pten in du145kd cells post-incubation with du145-derived exosomes did not result from the stimulation of pten transcription by exosomes, we performed rt-pcr for pten in du145kd cells treated with different concentrations of du145-derived exosomes. we observed an inhibitory effect on pten transcription (figure 2c). to further ensure that we were observing the intercellular transfer of pten protein, as opposed to the stimulation of transcription, we used the glioblastoma cell line u87, a null genotype, which contains a mutation in both pten alleles [33]. when treated with exosomes derived from du145 cells, u87 cells tested positive for pten (figure 2d). these data confirm that the acquired pten in du145kd and u87 is solely related to the intercellular transfer of pten protein through exosome exchange. in addition, we treated the prostate cancer cell line pc-3, which is pten null, with exosomes derived from du145 cells, showing the acquisition of pten (figure s1). we determined pten expression in exosomes from different cancer cell lines i.e. lung carcinoma (a549), breast cancer (mda-mb-231), colorectal carcinoma (hct116), and pancreas adenocarcinoma (bxpc-3) (figure s2, a), to show that pten is shed through exosomes from other cancer cell types. we also treated pc-3 cells with exosomes derived from hct116 colorectal carcinoma cells, and found that the pc-3 cells acquired pten expression (figure s2, b).",pmc3723640,1,10,1,1,11
388,pten,protein,,pten,uniprot,p60484,cytoplasm,go:0005737,pten,protein,,pten,uniprot,p60484,cytoplasm,go:0005737,positive,d,activation,,lung cancer cell lines,lung cancer,lung,human,['340'],nan,nan,"western blotting was performed in five lung cancer cell lines to evaluate total pten expression levels and the pten activation. in a xenograft model of lung cancer cells with endogenous pten expression, the pten expression was evaluated by immunohistochemistry. to examine the effect of hypoxia on phenotypic alterations in lung cancer cells in vitro, the cells were cultured under hypoxia. the effect of unphosphorylated pten (pten4a) induction on hypoxia-induced emt phenotypes was evaluated, by using a dox-dependent gene expression system.",pmc4836157,1,10,1,1,11
301,pten,protein,,pten,uniprot,p60484,cellulo,go:0044207,pten,protein,,pten,uniprot,p60484,,,positive,d,dimerization,cellulo,u2os osteosarcoma,,,human,['811'],nan,nan,"earlier this year, pandolfi and coworkers reported qualitative data suggesting that the overproduction of pten can lead to its dimerization in cellulo [21]. yet, a quantitative analysis of the proteome of u2os osteosarcoma cells growing in log phase detected <500 molecules of pten per cell, equivalent to a concentration of <0.2 nm [22]. at this low concentration, even with a nanomolar value of k",pmc4301912,1,10,1,1,11
772,ptenα,protein,translational variant,pten,uniprot,p60484,cytoplasm,go:0005737,pten,protein,canonical,pten,uniprot,p60484,cytoplasm,go:0005737,positive,d,translation,n-terminal extension,,,,human,['735'],nan,nan,"in previous studies both our group and hopkins et al. independently identified a translational variant of pten with n-terminal extension, designated ‘ptenα' in our study, and ‘pten-long' by hopkins et al.24. these have proven to be the same isoform that is translated from a cug codon 519 bp upstream of the aug initiation sequence of canonical pten (refs 24, 25). in addition to the initiation sites for ptenα and ptenβ (cug513, auu594), we found another two alternative non-aug codons in favourable kozak contexts, which may be sites for initiation of other as yet unidentified isoforms. as multiple additional forms of pten may exist, we consider it to be prudent to designate pten isoforms as a sequential series, using α, β, γ, δ as labels.",pmc5376652,1,10,1,1,11
